Japanese Society for Cancer of the Colon and Rectum (JS']JSCCR) guidelines 2019 for the treatment of colorectal cancer

被引：1450

作者：

Hashiguchi, Yojiro ^{[1
]}

Muro, Kei ^{[2
]}

Saito, Yutaka ^{[3
]}

Ito, Yoshinori ^{[4
]}

Ajioka, Yoichi ^{[5
]}

Hamaguchi, Tetsuya ^{[6
]}

Hasegawa, Kiyoshi ^{[7
]}

Hotta, Kinichi ^{[8
]}

Ishida, Hideyuki ^{[9
]}

Ishiguro, Megumi ^{[10
]}

Ishihara, Soichiro ^{[11
]}

Kanemitsu, Yukihide ^{[12
]}

Kinugasa, Yusuke ^{[13
]}

Murofushi, Keiko ^{[14
]}

Nakajima, Takako Eguchi ^{[15
]}

Oka, Shiro ^{[16
]}

Tanaka, Toshiaki ^{[11
]}

Taniguchi, Hiroya ^{[17
]}

Tsuji, Akihito ^{[18
]}

Uehara, Keisuke ^{[19
]}

Ueno, Hideki ^{[20
]}

Yamanaka, Takeharu ^{[21
]}

Yamazaki, Kentaro ^{[22
]}

Yoshida, Masahiro ^{[23
]}

Yoshino, Takayuki ^{[17
]}

Itabashi, Michio ^{[24
]}

Sakamaki, Kentaro ^{[25
]}

Sano, Keiji ^{[1
]}

Shimada, Yasuhiro ^{[26
]}

Tanaka, Shinji ^{[27
]}

Uetake, Hiroyuki ^{[28
]}

Yamaguchi, Shigeki ^{[29
]}

Yamaguchi, Naohiko ^{[30
]}

Kobayashi, Hirotoshi ^{[31
]}

Matsuda, Keiji ^{[1
]}

Kotake, Kenjiro ^{[32
]}

Sugihara, Kenichi ^{[33
]}

机构：

[1] Teikyo Univ, Dept Surg, Sch Med, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738606, Japan

[2] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[3] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan

[4] Showa Univ, Dept Radiat Oncol, Sch Med, Tokyo, Japan

[5] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan

[6] Saitama Med Univ, Dept Gastroenterol Oncol, Int Med Ctr, Saitama, Japan

[7] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Hepatobiliary, Tokyo, Japan

[8] Shizuoka Canc Ctr, Div Endoscopy, Shizuoka, Japan

[9] Saitama Med Univ, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Saitama, Japan

[10] Tokyo Med & Dent Univ Med Hosp, Dept Chemotherapy & Oncosurg, Tokyo, Japan

[11] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan

[12] Natl Canc Ctr, Dept Colorectal Surg, Tokyo, Japan

[13] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan

[14] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan

[15] St Marianna Univ, Dept Clin Oncol, Sch Med, Kawasaki, Kanagawa, Japan

[16] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima, Japan

[17] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan

[18] Kagawa Univ, Fac Med, Dept Clin Oncol, Takamatsu, Kagawa, Japan

[19] Nagoya Univ, Dept Surg, Div Surg Oncol, Grad Sch Med, Nagoya, Aichi, Japan

[20] Natl Def Med Coll, Dept Surg, Saitama, Japan

[21] Yokohama City Univ, Dept Biostat, Sch Med, Yokohama, Kanagawa, Japan

[22] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan

[23] Int Univ Hlth & Welf, Sch Med, Dept Hepatobiliary Pancreat & Gastrointestinal Su, Narita, Japan

[24] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan

[25] Yokohama City Univ, Ctr Data Sci, Yokohama, Kanagawa, Japan

[26] Kochi Hlth Sci Ctr, Div Clin Oncol, Kochi, Japan

[27] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan

[28] Tokyo Med & Dent Univ, Dept Specialized Surg, Tokyo, Japan

[29] Saitama Med Univ Int, Dept Gastroenterol Surg, Med Ctr, Hidaka, Japan

[30] SAKURA Citizen Hosp, Lib SEIREI, Sakura, Japan

[31] Teikyo Univ, Mizonokuchi Hosp, Dept Surg, Sch Med, Tokyo, Kanagawa, Japan

[32] Sano City Hosp, Dept Surg, Sano, Tochigi, Japan

[33] Tokyo Med & Dent Univ, Tokyo, Japan

来源：

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 25卷 / 01期

关键词：

Colorectal cancer; Guideline; Surgery; Chemotherapy; Endoscopy; Radiotherapy; RANDOMIZED PHASE-III; LYMPH-NODE DISSECTION; TOTAL MESORECTAL EXCISION; LONG-TERM OUTCOMES; ENDOSCOPIC SUBMUCOSAL DISSECTION; FLUOROURACIL PLUS LEUCOVORIN; REPEAT LIVER RESECTION; SYNCHRONOUS PERITONEAL METASTASIS; STEREOTACTIC BODY RADIOTHERAPY; PREOPERATIVE RADIATION-THERAPY;

D O I：

10.1007/s10147-019-01485-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The number of deaths from colorectal cancer in Japan continues to increase. Colorectal cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of treatments was performed, with corrections and additions made based on knowledge acquired since the 2016 version (drug therapy) and the 2014 version (other treatments). The Japanese Society for Cancer of the Colon and Rectum guidelines 2019 for the treatment of colorectal cancer (JSCCR guidelines 2019) have been prepared to show standard treatment strategies for colorectal cancer, to eliminate disparities among institutions in terms of treatment, to eliminate unnecessary treatment and insufficient treatment and to deepen mutual understanding between healthcare professionals and patients by making these guidelines available to the general public. These guidelines have been prepared by consensuses reached by the JSCCR Guideline Committee, based on a careful review of the evidence retrieved by literature searches and in view of the medical health insurance system and actual clinical practice settings in Japan. Therefore, these guidelines can be used as a tool for treating colorectal cancer in actual clinical practice settings. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. Controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSCCR guidelines 2019.

引用

页码：1 / 42

页数：42

共 308 条

[1]

Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71

[2] Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: Myth or reality? [J].